GlassScriptPhysician profile
Shelton A Mckenzie
NPI 1487811808
$22,089.09
in general payments reported to CMS, 2019-2025
33 companies · $2,805 in 2025
The $2,805 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,005 · 2020: $870 · 2021: $809 · 2022: $2,844 · 2023: $8,780 · 2024: $2,976 · 2025: $2,805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,965 · Travel and Lodging: $4,096 · Grant: $2,500 · Consulting Fee: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,965.31 |
| Travel and Lodging | $4,095.94 |
| Grant | $2,500.00 |
| Consulting Fee | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $7,192.05 | 2023-2024 | Colink Plating System, Colink Afx, Biobrace 23mm |
| Arthrex, INC. | $3,271.38 | 2019-2024 | |
| Supreme Orthopedic Systems, LLC | $2,583.10 | 2019-2025 | |
| Stryker Corporation | $2,512.56 | 2019-2025 | Variax, Triathlon, Augment Injectable |
| In2bones USA, LLC | $1,582.59 | 2019-2022 | |
| Smith+Nephew, INC. | $884.99 | 2019-2025 | Stravix Pl, Journey II, Polarstem |
| Depuy Synthes Sales INC. | $846.46 | 2019-2025 | Na, Monovisc, Truespan Orthocord |
| Bone Support INC. | $694.30 | 2021-2025 | Ceramentbone Void Filler, Cerament G |
| Medacta USA, INC. | $449.27 | 2021-2023 | Gmk Efficiency |
| Encore Medical, LP | $407.11 | 2022-2024 | Djo Surgical |
| Zimmer Biomet Holdings, INC. | $344.82 | 2024 | Tapestry, Affixus |
| Embody, INC. | $219.83 | 2022 | |
| Medtronic, INC. | $201.28 | 2023-2025 | Inceptiv, Intellis Adaptivestim |
| Baxter Healthcare | $146.03 | 2023 | Actifuse, Floseal, Altapore |
| Restor3d, INC. | $136.50 | 2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fusion Orthopedics USA, LLC | $106.26 | 2025 | |
| Ermi LLC | $99.03 | 2020-2023 | |
| Medline Industries LP | $49.81 | 2021 | |
| Deroyal Industries, INC. | $42.05 | 2024 | Flex Npwt Single Use System |
| Mimedx Group, INC. | $38.41 | 2025 | |
| Bioventus LLC | $36.76 | 2022 | |
| Medical Device Business Services, INC. | $33.07 | 2019 | |
| Abbott Laboratories | $26.11 | 2023 | Proclaim |
| Wright Medical Technology, INC. | $24.90 | 2020 | |
| Davol INC. | $21.79 | 2022 | |
| Avanos Medical | $21.51 | 2021 | |
| Medtronic USA, INC. | $20.43 | 2019 | |
| Integra Lifesciences Corporation | $20.20 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $19.75 | 2025 | Zilretta, Exparel |
| Masimo Corporation | $15.78 | 2022 | |
| Acell, INC. | $14.42 | 2020 | |
| Solventum Corporation | $14.28 | 2025 | Prevena |
| Pfizer INC. | $12.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelton Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.